Platelet Rich Plasma Market Scope
Platelet-rich plasma (PRP) is having more platelets typically found in the blood. The general concentration of platelets is varied nearly 5 to 10 times than usual. PRP is injected into injured areas in the body parts and also used to improve healing after surgery from injuries. The major factors which affect the PRP treatments include the area of the body, the overall health of patients, injury is acute or chronic. Platelet-rich plasma (PRP) is a recent development within the expanding field of regenerative medicine.
The market study is being classified by Type (Pure-Platelet Rich Plasma (P-PRP), Leukocyte-Platelet Rich Fibrin (L-PRF) and Leukocyte-Platelet Rich Plasma (L-PRP)), by Application (Orthopedics, Sports Medicine, Dentistry, Otolaryngology, Neurosurgery, Ophthalmology, Urology, Wound Healing and Others) and major geographies with country level break-up.
The global platelet-rich plasma market is highly competitive. The player dealing in this market focus on investing in R&D activities to develop new products. The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Platelet Rich Plasma market throughout the predicted period.
AdiStem Ltd. (Australia), Arthrex, Inc. (United States), Biomet, Inc. (United States), Cesca Therapeutics, Inc. (United States), DePuy Synthes, Inc. (United States), EmCyte Corporation (United States), Exactech, Inc. (United States), Harvest Technologies Corp. (United States), Nuo Therapeutics, Inc. (United States) and Regen Lab SA (Switzerland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Stryker Corporation (United States) and Healeon Medical, Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global Platelet Rich Plasma market by Type, Application and Region.
On the basis of geography, the market of Platelet Rich Plasma has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Origin, the sub-segment i.e. Allogeneic will boost the Platelet Rich Plasma market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In Jan 2019, Healeon Medical announced the new high-density platelet Rich plasma series. The company developed a PRP solution to meet the need for expanding demand for platelet-rich plasma.
- Increase Adoption for Acute Sports Injuries Treatments Such As Ligament and Muscle Injuries
- Growing Awareness about the Platelet Rich Plasma Therapy
- Increase Number of Chronic Tendon Injuries Treatment
- Increasing Number of Sports Professional Athletes across the Globe
- Growing Aging Population Being More Prone To Surgeries and Injuries
- High Costs of Therapies and Devices Can Hamper the Growth of Market
- Probability of Treatment Failure
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Platelet-rich plasma Manufacturers, Suppliers, and Distributors, Government Regulatory and Research Organizations and End-Use Industries
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase